The Centre for Brain Research (cbr-iisc.ac.in) at the Indian Institute of Science has embarked on a unique collaborative endeavour - a Biomarker Centre of Excellence in partnership with the UK Dementia Research Institute (UK DRI) and with support from Gates Ventures. This ambitious initiative aims to establish a sophisticated platform for the discovery and validation of neurodegenerative disease biomarkers. In addition to plasma biomarkers, the Centre will also explore digital biomarkers to build a more comprehensive understanding of disease onset and progression. A unique strength of this Centre of Excellence is that it will function under the scientific guidance of Professor Henrik Zetterberg (UK DRI and University of Gothenburg), a globally recognised pioneer in biomarker research, and Professor Siddharthan Chandran, Director of the UK DRI, both of whom are Visiting Faculty Members at CBR. The Centre will integrate the state-of-the-art in fluid biomarker assays, high-throughput proteomics, and AI-driven analytics with unique, diverse cohorts from India and the UK in order to accelerate breakthroughs in early diagnosis. It will foster cross-institutional partnerships, training, and knowledge exchange to build capacity and advance global brain health research. The Data Scientist will play a central role in analysing and integrating complex biomarker datasets to advance discovery and validation of neurodegenerative disease biomarkers. This role requires expertise in data science, statistical modelling, and AI/ML approaches, combined with an understanding of biological and clinical contexts. The Data Scientist will collaborate closely with laboratory scientists, clinicians, and international partners, including the UK Dementia Research Institute, to extract meaningful insights from large-scale fluid biomarker, multi-omics, clinical, and imaging data. The Data Scientist will report to the Lead, Biomarker Centre of Excellence.

The Centre for Brain Research (cbr-iisc.ac.in) at the Indian Institute of Science has embarked on a unique collaborative endeavour - a Biomarker Centre of Excellence in partnership with the UK Dementia Research Institute (UK DRI) and with support from Gates Ventures. This ambitious initiative aims to establish a sophisticated platform for the discovery and validation of neurodegenerative disease biomarkers. In addition to plasma biomarkers, the Centre will also explore digital biomarkers to build a more comprehensive understanding of disease onset and progression. A unique strength of this Centre of Excellence is that it will function under the scientific guidance of Professor Henrik Zetterberg (UK DRI and University of Gothenburg), a globally recognised pioneer in biomarker research, and Professor Siddharthan Chandran, Director of the UK DRI, both of whom are Visiting Faculty Members at CBR. The Centre will integrate the state-of-the-art in fluid biomarker assays, high-throughput proteomics, and AI-driven analytics with unique, diverse cohorts from India and the UK in order to accelerate breakthroughs in early diagnosis. It will foster cross-institutional partnerships, training, and knowledge exchange to build capacity and advance global brain health research. The Research Technician will support biomarker discovery and validation projects by performing laboratory assays, maintaining high standards of data quality, and ensuring that sample handling, processing, and reporting are carried out according to best practices. The role requires meticulous laboratory work, proactive problem-solving, and close collaboration with the multidisciplinary team at CBR and external partners including the UK DRI. The Research Technician will report to the Lead, Biomarker Centre of Excellence.

The Centre for Brain Research (cbr-iisc.ac.in) at the Indian Institute of Science has embarked on a unique collaborative endeavour - a Biomarker Centre of Excellence in partnership with the UK Dementia Research Institute (UK DRI) and with support from Gates Ventures. This ambitious initiative aims to establish a sophisticated platform for the discovery and validation of neurodegenerative disease biomarkers. In addition to plasma biomarkers, the Centre will also explore digital biomarkers to build a more comprehensive understanding of disease onset and progression. A unique strength of this Centre of Excellence is that it will function under the scientific guidance of Professor Henrik Zetterberg (UK DRI and University of Gothenburg), a globally recognised pioneer in biomarker research, and Professor Siddharthan Chandran, Director of the UK DRI, both of whom are Visiting Faculty Members at CBR. The Centre will integrate the state-of-the-art in fluid biomarker assays, high-throughput proteomics, and AI-driven analytics with unique, diverse cohorts from India and the UK in order to accelerate breakthroughs in early diagnosis. It will foster cross-institutional partnerships, training, and knowledge exchange to build capacity and advance global brain health research. The Research Scientist will join the multidisciplinary team at the CBR Biomarker Centre of Excellence to advance discovery and validation of fluid biomarkers relevant to neurodegenerative diseases. The role will entail designing and conducting experiments, analysing large-scale biomarker data, and collaborating closely with national and international partners. The Research Scientist will also contribute to maintaining high scientific and quality standards within the Centre and play an active role in capacity building, knowledge exchange, and dissemination of research findings. This position will report to the Lead, Biomarker Centre of Excellence.

The Centre for Brain Research (cbr-iisc.ac.in) at the Indian Institute of Science has embarked on a unique collaborative endeavour - a Biomarker Centre of Excellence in partnership with the UK Dementia Research Institute (UK DRI) and with support from Gates Ventures. This ambitious initiative aims to establish a sophisticated platform for the discovery and validation of neurodegenerative disease biomarkers. In addition to plasma biomarkers, the Centre will also explore digital biomarkers to build a more comprehensive understanding of disease onset and progression. A unique strength of this Centre of Excellence is that it will function under the scientific guidance of Professor Henrik Zetterberg (UK DRI and University of Gothenburg), a globally recognised pioneer in biomarker research, and Professor Siddharthan Chandran, Director of the UK DRI, both of whom are Visiting Faculty Members at CBR. The Centre will integrate the state-of-the-art in fluid biomarker assays, high-throughput proteomics, and AI-driven analytics with unique, diverse cohorts from India and the UK in order to accelerate breakthroughs in early diagnosis. It will foster cross-institutional partnerships, training, and knowledge exchange to build capacity and advance global brain health research. The Facility Coordinator will ensure smooth and efficient day-to-day operations of the Biomarker Centre of Excellence (CoE). Reporting to the Director of CBR and working closely with Lead – Proteomics and Lead – Digital Biomarkers, this role combines administrative oversight, operational support, and coordination across research and technical teams.

The Centre for Brain Research (cbr-iisc.ac.in) at the Indian Institute of Science has embarked on a unique collaborative endeavour - a Biomarker Centre of Excellence in partnership with the UK Dementia Research Institute (UK DRI) and with support from Gates Ventures. This ambitious initiative aims to establish a sophisticated platform for the discovery and validation of neurodegenerative disease biomarkers. In addition to plasma biomarkers, the Centre will also explore digital biomarkers to build a more comprehensive understanding of disease onset and progression. A unique strength of this Centre of Excellence is that it will function under the scientific guidance of Professor Henrik Zetterberg (UK DRI and University of Gothenburg), a globally recognised pioneer in biomarker research, and Professor Siddharthan Chandran, Director of the UK DRI, both of whom are Visiting Faculty Members at CBR. The Centre will integrate the state-of-the-art in fluid biomarker assays, high-throughput proteomics, and AI-driven analytics with unique, diverse cohorts from India and the UK in order to accelerate breakthroughs in early diagnosis. It will foster cross-institutional partnerships, training, and knowledge exchange to build capacity and advance global brain health research. The Lead for Digital Biomarkers will spearhead the scientific direction, operational execution, and strategic expansion of the digital biomarker initiatives of the Centre of Excellence (CoE). This role requires robust expertise in digital health technologies and AI/ML and the ability to translate digital endpoints into impactful clinical research for neurodegenerative and cerebrovascular conditions. The Lead will oversee discovery, validation, and integration of digital biomarkers within broader translational workflows. The Lead will report to the Director of CBR.

The Centre for Brain Research (cbr-iisc.ac.in) at the Indian Institute of Science has embarked on a unique collaborative endeavour - a Biomarker Centre of Excellence in partnership with the UK Dementia Research Institute (UK DRI) and with support from Gates Ventures. This ambitious initiative aims to establish a sophisticated platform for the discovery and validation of neurodegenerative disease biomarkers. In addition to plasma biomarkers, the Centre will also explore digital biomarkers to build a more comprehensive understanding of disease onset and progression. A unique strength of this Centre of Excellence is that it will function under the scientific guidance of Professor Henrik Zetterberg (UK DRI and University of Gothenburg), a globally recognised pioneer in biomarker research, and Professor Siddharthan Chandran, Director of the UK DRI, both of whom are Visiting Faculty Members at CBR. The Centre will integrate the state-of-the-art in fluid biomarker assays, high-throughput proteomics, and AI-driven analytics with unique, diverse cohorts from India and the UK in order to accelerate breakthroughs in early diagnosis. It will foster cross-institutional partnerships, training, and knowledge exchange to build capacity and advance global brain health research. The Lead for Proteomics will provide strategic, scientific, and operational leadership for the Biomarker Centre of Excellence (CoE). Therefore, this role requires a combination of scientific expertise, strategic foresight, team management, and collaborative engagement. Besides overseeing research projects and mentoring a multidisciplinary team, the Lead will ensure rigorous quality standards for biomarker research and serve as the primary liaison to internal and external partners in this endeavour. The Lead will report to the Director, CBR.